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Differentiation of adipose-derived stem cells into
Schwann cell phenotype induces expression of P2X
receptors that control cell death
A Faroni*,1,2, SW Rothwell2, AA Grolla2, G Terenghi1, V Magnaghi3 and A Verkhratsky2
Schwann cells (SCs) are fundamental for development, myelination and regeneration in the peripheral nervous system. Slow
growth rate and difficulties in harvesting limit SC applications in regenerative medicine. Several molecules, including receptors
for neurosteroids and neurotransmitters, have been suggested to be implicated in regulating physiology and regenerative
potential of SCs. Adipose-derived stem cells (ASCs) can be differentiated into SC-like phenotype (dASC) sharing morphological
and functional properties with SC, thus representing a valid SC alternative. We have previously shown that dASC express
c-aminobutyric-acid receptors, which modulate their proliferation and neurotrophic potential, although little is known about the
role of other neurotransmitters in ASC. In this study, we investigated the expression of purinergic receptors in dASC. Using
reverse transriptase (RT)-PCR, western blot analyses and immunocytochemistry, we have demonstrated that ASCs express
P2X3, P2X4 and P2X7 purinoceptors. Differentiation of ASCs towards glial phenotype was accompanied by upregulation of P2X4
and P2X7 receptors. Using Ca
2þ -imaging techniques, we have shown that stimulation of purinoceptors with adenosine
50-triphosphate (ATP) triggers intracellular Ca2þ signals, indicating functional activity of these receptors. Whole-cell voltage
clamp recordings showed that ATP and BzATP induced ion currents that can be fully inhibited with specific P2X7 antagonists.
Finally, using cytotoxicity assays we have shown that the increase of intracellular Ca2þ leads to dASC death, an effect that can
be prevented using a specific P2X7 antagonist. Altogether, these results show, for the first time, the presence of functional P2X7
receptors in dASC and their link with critical physiological processes such as cell death and survival. The presence of these
novel pharmacological targets in dASC might open new opportunities for the management of cell survival and neurotrophic
potential in tissue engineering approaches using dASC for nerve repair.
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There is a need for alternative strategies to the treatment of
peripheral nerve injuries.1 Traumatic lesions of peripheral
nerves are common; they affect the quality of patients’ life and
result in substantial health-care expenditure.2,3 Although
surgical techniques have seen great advances in recent
years, the outcomes of peripheral nerve regeneration remain
poor.4 In order to improve functional recovery after regene-
ration, efforts are applied to the development of bioengineered
nerve grafts consisting of nerve guidance tubes, or conduits,
which could be enriched with extracellular matrix molecules,
growth factors or transplantable cells.5
Nerve injury involves the response of Schwann cells (SCs),
the glial cells of the peripheral nervous system.6 Damage to
the nerve induces remodelling of SC phenotype that
eventually aids the outgrowing axon to reach the target
of reinnervation.7,8 For these reasons, SCs were the first cells
to be transplanted in bioengineered nerve grafts, thereby
improving nerve regeneration;9–11 however, the slow expan-
sion rate and difficulties in harvesting limit deployment of SCs
as transplantable cells.12 Adipose-derived stem cells (ASCs)
are a clinically viable alternative to SC.13–18 SC-like diffe-
rentiated ASCs (dASC) express glial markers and growth
factors,14,18 produce myelin,15,19,20 induce neurites outgrowth
in vitro 14,20,21 and promote nerve regeneration in vivo.22–25
Cell transplantation technologies depend upon the survival
of transplanted cells that defines the final outcome. In the case
of cell transplantation for nerve repair, the survival rates of
transplanted cells are not always reported; however, most
studies estimated these between 0.5 and 38%, depending on
cell type and evaluation time point(s).26–28 Despite relatively
low survival rate, cell transplantation improves nerve
regeneration, probably because of an initial boost generated
by the transplanted cells, which arguably may recruit
endogenous SC.26,27 Nonetheless, improving the survival
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rate and the neurotrophic potential of dASC could be the key
requirement for their clinical employability in nerve repair.
Several molecules such as neurosteroids, growth
hormones and neurotransmitters have been suggested as
potential pharmacological modulators of SC physiology.29 In
particular, neurotransmitters such as g-aminobutyric acid
(GABA) and adenosine 50-triphosphate (ATP) have been shown
to affect SC functional responses and differentiation.30–34
Recently, we have shown that dASC express functional GABAA
and GABAB receptors that modulate SC proliferation and
release of neurotrophic factors.35–37 The expression of other
neurotransmitter receptors in dASC has not been investigated,
although purinergic receptors influence the adipogenic and
osteogenic differentiation of human ASC.38
Purinergic signalling is one of the most pervasive mecha-
nisms of intercellular communication, known to control
physiological functions of glial cells, such as proliferation,
motility, survival, differentiation and myelination.39,40 Purino-
ceptors are classified as metabotropic P1 adenosine recep-
tors, metabotropic P2Y purinoceptors and ionotropic P2X
purinoceptors.40 P2X receptors are ligand-gated cationic
channels, which assemble in trimeric form (either homo- or
heteromultimers) from seven different subunits (designated
as P2X1–7).
40,41 Stimulation of purinergic receptors has been
associated with multiple long-term trophic effects, involved in
the regulation of cell replication, proliferation, differentiation
and cell death.42 Tissue damage is often associated with
massive increase of ATP on the injury site, which induces
neuronal cell death following spinal cord injuries, an effect that
is prevented by P2X7-specific antagonists.
43
The aim of this study was to determine the presence of
functional purinoceptors in dASC and to identify the asso-
ciation between activation of purinoceptors and cell death, an
effect that could be responsible for the low survival rate of
dASC when transplanted in nerve injury models. Purino-
ceptors could provide a new pharmacological target to
improve cell survival in bioengineered nerve grafts for the
treatment of peripheral nerve injuries.
Results
dASCs express mRNAs of multiple P2X receptors.
Following a previously established protocol,35,36 undiffe-
rentiated ASCs (uASC) were successfully differentiated into
SC-like cells. Following harvesting, uASC presented a typical
fibroblast-like flattened morphology (Figure 1a). After
2 weeks of differentiation in glial conditioning media, cells
acquired a spindle-shaped morphology (Figure 1b) similar to
genuine nerve-derived neonatal SC (nSC) that were used as
controls (Figure 1c). Successful differentiation was also
confirmed by expression of glial markers, as previously
described.14,35,36 Representative glial fibrillary acidic protein
(GFAP) immunostainings of uASC, dASC and nSC are
shown in red in Figures 1d–f, respectively.
The presence of mRNAs for the P2X1 7 purinoceptors was
assessed by reverse-transcriptase PCR (RT-PCR). Specific
primers listed in Table 1 were used to detect amplicons for the
different P2X receptors. A specific product of 440 bp
corresponding to P2X3 receptor was detected in both uASC
and dASC as well as in the controls nSC and adult SC (aSC)
(Figure 2). SC-like differentiation did not seem to affect P2X3
mRNA levels. A 447-bp product, corresponding to P2X4
receptor was detected in uASC and seemed to be increased
following glial differentiation. P2X4 mRNAs were found also in
the positive controls nSC and aSC. Similarly, P2X7 transcripts
(354 bp) were found to be strongly upregulated in dASC with
levels comparable to the positive controls (Figure 2).
P2X1, P2X2 and P2X5 mRNAs were not detected despite
increasing the amount of starting mRNA template to
10 ng (data not shown). A reaction with 10 ng of mRNA
produced specific amplicons for P2X6 receptors in aSC and
nSC (rather faint signal); however, no signal was detected in
uASC and dASC (Figure 2).
P2X4 and P2X7 receptor proteins are upregulated in
dASC. The expression of P2X4 and P2X7 receptors was
also investigated at a protein level by western blot analysis.
Using a specific antibody raised against P2X4 receptor,
a specific band of 50–60 kDa was found in dASC, aSC and
nSC, but not in uASC (Figure 3a). Similarly, P2X7 receptor
protein (70–80 kDa) was strongly upregulated in dASC,
confirming RT-PCR studies (Figure 3a). aSC and nSC were
used as positive controls for western blot studies. Blotting for
the housekeeping gene b-tubulin confirmed equal loading.
Localisation of P2X4 and P2X7 receptor in uASC and dASC
was further investigated with immunocytochemistry analyses,
and was compared with receptor distribution in nSC. The
uASCs presented only faint staining for P2X4 and P2X7
(green, Figures 3b and e, respectively). Immunoreactivities
for both P2X4 (Figure 3c) and P2X7 (Figure 3f) were increased
in the course of glial differentiation. Increased staining was
observed in the cells that underwent glial differentiation with
a characteristic change of morphology indicative of
differentiated state. Previous quantitative analyses from our
group have indicated that 81.5±1.5% cells undergo morpho-
logical change.14 Distribution of P2X4 and P2X7 was detected
throughout the cytoplasm of dASC, with distribution pattern
similar to nSC (Figures 3d and g).
Stimulation of purinoceptors in dASC evokes intra-
cellular Ca2þ signals. Using a Ca2þ -sensitive dye
(Fura-2), concentration dependence of ATP-induced
cytoplasmic Ca2þ changes in uASC and dASC were
recorded with a Flexstation microplate reader. Both uASC
(Figure 4a) and dASC (Figure 4b) showed a rapid
dose-dependent increase in Ca2þ -dependent intracellular
fluorescence. The pattern and concentration dependence of
responses were, however, different in the two cell types
confirming the putative presence of a different complements
of purinergic receptors, as suggested by molecular studies.
Indeed, whereas uASC response to ATP saturated at 100mM,
in dASC intracellular Ca2þ signals did not saturate even at
1 mM ATP (Figure 4c). Intracellular Ca2þ increase following
ATP stimulation was further confirmed by confocal imaging
using a different Ca2þ -sensitive dye (Fluo-4). Levels of
fluorescence (green) were rapidly and strongly increased in
the majority of the dASC treated with 1 mM of ATP (Figure 4g).
To investigate the contribution of the metabotropic P2Y
receptors, experiments were repeated in the absence of
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Figure 1 Differentiation of ASC into glial phenotype. (a) uASCs show fibroblast-like morphology that changed following exposure to glial induction media.
(b) dASC show spindle-shaped morphology typical of SC, these later displayed in (c). (d, e and f) Staining for the glial marker GFAP confirmed successful differentiation
of dASC (red in e), with a similar pattern of localisation as nSC (f) used as control uASCs (d) showed only faint GFAP staining. Nuclei are stained with DAPI
(40,6- diamidino-2-phenylindole)
Table 1 Specific primers used for RT-PCR studies
Gene AN GenBank Primer sequence (50–30) AT (1C) PL (bp)
P2X1 X80447 F: GAAGTGTGATCTGGACTGGCACGT 58 452
R: GCGTCAAGTCCGGATCTCGACTAA
P2X2 U14414 F: GAATCAGAGTGCAACCCCAA 61 357
R: TCACAGGCCATCTACTTGAG
P2X3 X90651 F: TGGCGTTCTGGGTATTAAGATCGG 58 440
R: CAGTGGCCTGGTCACTGGCGA
P2X4 X87763 F: GAGGCATCATGGGTATCCAGATCAAG 58 447
R: GAGCGGGGTGGAAATGTAACTTTAG
P2X5 X92069 F: GCCGAAAGCTTCACCATTTCCATAA 58 418
R: CCTACGGCATCCGCTTTGATGTGATAG
P2X6 X92070 F: AAAGACTGGTCAGTGTGTGGCGTTC 64 520
R: TGCCTGCCCAGTGACAAGAATGTCAA
P2X7 X95882 F: GTGCCATTCTGACCAGGGTTGTATAAA 58 354
R: GCCACCTCTGTAAAGTTCTCTCCGATT
b-actin NM031144 F: CACCACAGCTGAGAGGGAAATCGTGCGTGA
R: ATTTGCGGTGCACGATGGAGGGGCCGGACT
60 510
Abbreviations: AN GenBank, accession number; AT, annealing temperature; F, forward; PL, product length; R, reverse.
Sequences from Shibuya et al 61
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extracellular Ca2þ . Both uASC (Figure 4d) and dASC
(Figure 4e) showed ATP-induced Ca2þ response despite
the absence of Ca2þ in an extracellular reservoir, suggesting
the release of Ca2þ from intracellular stores linked, in all
probability, to activation of P2Y receptors. Concentration
dependence of Ca2þ responses was different between uASC
and dASC, suggesting that expression pattern of P2Y
receptors may also be remodelled following glial
differentiation. Indeed, whereas in uASC the ATP-dependent
Ca2þ fluorescence was saturated at 30 mM ATP, in dASC
saturation was reached only at 300 mM ATP (Figure 4f).
To identify the P2X-mediated component of intracellular
Ca2þ increase, specific P2X7 inhibitors were used to block
the receptors before ATP stimulation. Ca2þ signals
recorded from dASC in response to 1 mM ATP were
significantly inhibited by the treatment with a potent and
specific antagonist for P2X7 receptor (AZ 10606120
dihydrochloride, 300 nM), suggesting the presence of
functional P2X7 receptors. The area under the curve
(AUC) of the Ca2þ traces recorded from the samples
pretreated with the inhibitor was indeed significantly
reduced (10.09±0.45) compared with the
samples treated only with ATP (17.69±0.45, AUC arbi-
trary units, n¼ 4, **Po0.01, Figure 4i). Another potent,
selective and competitive P2X7 receptor antagonist
(A740003, 60 mM) produced a similar effect (9.76±0.32
ATP versus 7.22±0.15 ATP plus inhibitor, n¼ 4,
***Po0.001, data not shown). Conversely, pretreatment
of uASC with the AZ 10606120 compound did not affect
Ca2þ signals confirming that functional P2X7 receptors
are not present in uASC (Figure 4h).
ATP and BzATP trigger P2X7-mediated ion currents.
We further characterised functional expression of P2X
receptors in dASCs utilising whole-cell voltage clamp.
Either ATP (3 mM–3 mM) or BzATP (20(30)-O-(4-Benzoyl-
benzoyl)adenosine-50-triphosphate tri(triethylammonium)
salt; 3–300 mM) were applied for 30 s at 60-s intervals.
Inward currents were observed in dASCs only when
ATP was applied at a concentration of 1 mM or higher
(Figures 5a and b). BzATP was more potent than ATP,
evoking currents when applied at concentrations starting
at 30 mM (Figures 5a and b). ATP-evoked currents were
non-desensitizing in the presence of ATP, suggesting
operation of P2X7 receptors. This was further corroborated
by testing the effect of the specific P2X7 inhibitor, AZ
10606120, on ATP-evoked currents in dASC. The AZ
10606120 compound (300 nM) inhibited ATP-evoked
currents by 84±3% (n¼ 7), indicating significant contribution
of P2X7 receptors (Figures 5c and d). We were not able to
measure currents from uASC owing to the flat morphological
nature that makes whole-cell patch clamping technically
challenging.
P2X7 receptors mediate dASC cell death and survival.
One of the fundamental effects mediated through activation
of P2X7 receptor is to induce cell death.
44,45 In order to
determine the ATP concentration that, during sustained
stimulation, could initiate cell death, we performed a lactate
dehydrogenase (LDH) cytotoxicity assay on cultures treated
with 0–10 mM ATP. Although 1 mM ATP did not induce cell
death, a significant increase in cytotoxicity was observed in
cultures treated with 5 mM (**Po0.01) and 10 mM
(****Po0.0001) of ATP (Figure 6b). For this reason, 5 mM
ATP was chosen for the rest of cell death studies. In order to
assess whether the observed cell death was dependent from
P2X7 receptors activation, cultures were treated with 5 mM
ATP together with specific P2X7 antagonists. Cells treated
with 5 mM ATP showed a significantly increased level of cell
death (19.03±0.67%) compared with untreated cultures
(11.59±0.59%, ****Po0.0001, Figure 6c). Pretreatment
with the AZ 10606120 compound (300 nM) prevented this
ATP-induced cell death and significantly reduced the level of
cytotoxicity (11.56±0.39%, ****Po0.0001). These effects
were also observed by examination under a bright field
microscope (Figure 6a). In samples treated with ATP, dASC
assumed a rounded morphology typical of dying cells and
were eventually detached, an effect prevented by preincu-
bation of cultures with P2X7 antagonist (Figure 6a). In order
to assess cell viability following ATP treatments,
a [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium], (MTS)-based cell survival
assay was performed (Figure 6d). Treatment with 5 mM ATP
significantly reduced dASC viability compared with untreated
controls (90.21±1.29% versus 100.0±1.64%, ***Po0.001),
confirming LDH results. Pretreatment with AZ 10606120
dihydrochloride (300 nM) prevented the ATP-mediated
decrease of cell viability and restored the survival rate of
treated dASC at the levels of the non-treated cells
(101.4±1.47%, ***Po0.001). Furthermore, a third cell
viability assay, based on a membrane-impermeant viability
Figure 2 Qualitative RT-PCR for P2X receptors. ASCs were found to express
mRNAs for P2X3 and P2X4 receptors. P2X4 and P2X7 receptors were upregulated
in dASC. However, P2X6 transcripts were not detected in ASC despite increasing
the amount of the starting RNA template. aSC, nSC total RNA were used as positive
controls. b-actin was used as a loading control and a reaction omitting the template
was used as a negative control
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Figure 3 P2X4 and P2X7 receptor proteins are upregulated in dASC. (a) P2X4 and P2X7 proteins were not detected in uASC by western blot analysis. Both P2X4 and P2X7
receptor proteins were upregulated in dASC to levels comparable to aSC and nSC. The housekeeping gene b-tubulin was used to verify equal loading. (b–g) Staining for P2X4
receptors is faint in uASC (b) and strongly increased in dASC (c), with a pattern similar to nSC (d). Similarly, uASC showed poor positive staining for P2X7 receptor (e), but
staining was increased in dASC (f) becoming comparable to nSC (g). P2X receptors are stained in green and nuclei are stained with DAPI (40,6- diamidino-2-phenylindole).
Negative controls with omission of primary antibodies were performed for each cell type and showed no staining (data not shown)
P2X7 receptors mediate SC-like stem cell death
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indicator ethidium homodimer-1 (EthD-1), was performed.
The number of cell stained with EthD-1 was significantly
increased in the samples treated with 5 mM ATP compared
with non-treated (NT) controls (617±33 versus 188±17,
n¼ 6, ***Po0.001). Nonetheless, preincubation with the AZ
10606120 dihydrochloride compound (300 nM) prevented the
ATP-dependent increase of dead cells and reduced the
number of dead cells stained with EthD-1 to the level of NT
controls of 224±71, n¼ 6 (Figure 6e).
Discussion
In this study, we have shown for the first time that specific
purinoceptors are upregulated in ASCs differentiated into a
SC-like phenotype and that they control cell death and survival.
In recent years, dASCs have been suggested as
a promising source of transplantable cells for peripheral nerve
repair.1 Several in vitro and in vivo studies demonstrated that
dASCs share morphological, molecular and functional
Figure 4 Intracellular Ca2þ signalling induced by stimulation with ATP. (a–c and g) uASC (a) and dASC (b) showed a dose-dependent increase of intracellular
Ca2þ concentration following exposure to ATP, as measured by Fura-2 fluorescence (n¼ 3). uASC and dASC showed a different ATP sensitivity (c), as shown from the
quantified AUCs normalised for the maximal response. Intracellular Ca2þ increase following ATP treatment (1 mM) was also confirmed by confocal imaging of dASC cultures
stained with Fluo-4 (g). (d–f) P2Y contribution to intracellular Ca2þ increase was assessed by performing Ca2þ recordings in Ca2þ -free extracellular solutions; uASC (d) and
dASC (e) showed a different pattern of responses, which saturated at different ATP concentrations (f) n¼ 3. (h and i) In dASC (i), incubation with A10606120 dihydrochloride
(300 nM), a potent and specific P2X7 antagonist, significantly reduced the intracellular Ca
2þ increase evoked by ATP treatments (n¼ 4, **Po0.01). This was not observed in
uASC (h). Statistical analysis was performed using unpaired t-test. Treatments with drug vehicle did not induce any fluorescence changes
P2X7 receptors mediate SC-like stem cell death
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similarities with native SC, with the additional advantage of
being easily cultured and rapidly expandable.14,19,22,23,46
When transplanted in rat in vivo models of peripheral nerve
injury, they were able to promote regeneration and remyeli-
nate injured axons.18,20,22,23 We have previously shown that
GABAB receptors expressed in dASCs represent a potential
pharmacological target to improve their neurotrophic
potential.35–37 Pharmacological targeting of dASC neuro-
transmitters receptors could constitute a clinically viable
option for the development of cell-based therapies for
peripheral nerve injuries.
Embryonic stem cells, hematopoietic stem cells, bone
marrow stem cells and neuronal progenitors have been
shown to respond to ATP stimulation, but the specific pattern
of receptors responsible for such responses remains virtually
unknown.38 In this paper, we have demonstrated that ASCs
express specific subtypes of P2X ionotropic purinoceptors.
The expression of P2X3, P2X4 and P2X7 receptors, but not
P2X1 and P2X2 mRNAs was detected, which is in accordance
with a recent study in human ASCs.38 In contrast to previous
data, however, we were not able to detect P2X5 and P2X6
receptors mRNAs. This difference could reflect different
cell culture conditions or interspecies differences. In uASC,
P2X4-specific mRNA transcripts were detected, whereas
protein was not. This discrepancy could be attributed to a
different turnover of P2X4 mRNA and proteins, as well as to
the diverse detection limits of the two techniques.
Differentiation along a glial phenotype was accompanied by
upregulation of P2X4 and P2X7 receptors that complements
other reports demonstrating a rearrangement in expression
when differentiated towards an adipogenic or osteogenic
phenotype.39 It is known that myelinating potential and
proliferation is regulated through ATP acting on P2
purinoceptors on SCs during development.47 The role of
purinoceptors in long-term trophic signalling pathways
affecting cell proliferation, differentiation, motility and death
is well known.42 In particular, P2X7 receptors have been
shown to mediate cell death in a wide variety of cell types,
most notably oligodendrocytes.40,42 Indeed, oligodendrocytes
express P2X7 receptors, which can induce cell death, causing
lesions that resemble demyelinating conditions such as
multiple sclerosis.48 This suggests the possibility of targeting
glial P2X7 receptors for the management of demyelinating
conditions of the central nervous system. Opening of P2X7
receptors requires much higher (in mM range) ATP concen-
trations than other P2X receptor subtypes (in mM range).
Transient ATP stimulation opens the P2X7 channel to
small cations (that is, Naþ , Kþ and Ca2þ ), whereas a
continued exposure to ATP triggers the formation of larger
transmembrane pores, determining excessive Ca2þ influx
with consequent changes in intracellular ions and metabolites
concentrations, leading to cell death.49,50
We have found that stimulation of both uASCs and dASCs
with ATP triggers transient increase in the intracellular
Ca2þ concentration. Concentration dependence of these
Ca2þ signals differed between undifferentiated and
differentiated cells. uASCs Ca2þ responses saturated at
B100 mM ATP, whereas dASCs Ca2þ responses continued
to rise at concentrations of ATP of up to 1 mM. In both types
of cells, Ca2þ responses were maintained in the absence of
extracellular Ca2þ , indicating activation of metabotropic P2Y
receptors; however, only in dASC we detected the component
of Ca2þ response activated by high ATP concentrations that
was inhibited by specific antagonists of P2X7 receptors.
Figure 5 P2X7 ion currents in dASCs. (a) Representative recordings of ion currents measured from dASC in response to application of increasing concentrations of ATP
(upper traces) and BzATP (lower traces); agonists were applied for 30 s with 60-s intervals. (b) The concentration dependence of peak amplitude of ion currents recorded as in
(a); n¼ 6–10 for ATP and 5–10 for BzATP. (c and d) Inhibition of ATP-induced ion currents by P2X7 antagonist AZ 10606120; ATP was applied at 3 mM for 30 s; AZ 10606120
at 300 nM was added to the bath 1–2 min before ATP challenge and remained in the presence of ATP; the average values for peak amplitudes in control and in the presence of
the antagonist are shown in (d). Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test, n¼ 7, *Po0.05
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A Faroni et al
7
Cell Death and Disease
In voltage-clamped dASCs, the non-desensitising current
was evoked by ATP at concentrations exceeding 1 mM; a
similar non-desensitising current was induced by BzATP
applied at concentrations above 30 mM. This ATP-induced ion
current was almost completely blocked by specific P2X7
antagonist AZ 10606120. Low-sensitivity to ATP, absence of
desensitisation, agonism by BzATP and antagonism by AZ
10606120 compound collectively substantiate functional
expression of P2X7 receptors in dASCs. These P2X7
receptors represent the sole component of ionotropic
response to ATP, because no currents were detected at
ATP applied in concentrations below 1 mM. It is noteworthy
that P2Y-mediated Ca2þ responses (measured in the
absence of extracellular Ca2þ ) also differed between uASC
and dASC, indicating possible remodelling of P2Y receptors
complement related to cells differentiation, although this
requires further investigation.
Functional and expression data indicate that in the process
of differentiation to SC phenotype, dASCs acquire functional
P2X7 receptors. These receptors can be linked to dASC
survival because an extended exposure to high concen-
trations of ATP results in cell death linked to their activation.
Using cell viability assays, paired with morphological obser-
vations, we showed that the pharmacological preconditioning
of dASC with a specific P2X7 antagonist prevented this
P2X7-mediated cell death. It is important to consider that the
P2X7-mediated ATP-induced cell death is not necessarily
uniquely linked to the increase of intracellular Ca2þ . Indeed,
in voltage-clamped dASC, 1 mM ATP induced P2X7-specific
ion currents but this did not translate in dASC cell death,
as observed in cell viability studies. Nonetheless, higher
concentrations of ATP were shown to fully activate P2X7
receptors on dASC, and sustained ATP exposure caused cell
death. For this reason, the presence of other mechanisms
(besides intracellular Ca2þ increase), likely to result from
P2X7 pore formation, should not be excluded and may be
worth further investigation.
The presence of functional P2X7 receptors mediating dASC
cell death could represent a novel pharmacological target to
improve the survival rate of dASC in stem cell-based
approaches for nerve repair. Although cell transplants were
able to support axonal regeneration, only 12% of SC-like bone
marrow-derived stem cells were found in peripheral nerve
grafts 3 weeks after surgery.51 Similarly, only 26 000 of
SC-like skin-derived precursors out of the 400 000 cells
originally transplanted were found in remyelinated peripheral
nerves 6 weeks after transplantation.52 Quantitative data on
the survival of dASC following transplantation in nerve injury
models are not available; nevertheless, green fluorescent
protein-labelled uASCs were not detected 2 weeks after
transplantation.26 The enhanced axonal regeneration
reported in this in vivo model was attributed to an indirect
Figure 6 P2X7 activation mediates dASC cell death. (a) After 1 h incubation with 5 mM of ATP, cells acquired a rounded morphology typical of dying cells. Cell death was
prevented by preincubation with the specific P2X7 antagonist AZ 10606120 dihydrochloride (300 nM), as shown by bright field images. NT, non-treated controls. (b) LDH assay
was used to measure cytotoxicity following ATP (1–10 mM) treatments, and a significant increase of cell death was observed only at 5 and 10 mM ATP. (c) AZ 10606120
dihydrochloride significantly reduced the ATP-induced cytotoxicity to levels comparable to the controls. Data were normalised to the LDH levels of Triton-X lysates and
expressed as percentage of cytotoxicity±S.E.M. (d) An MTS assay was performed to measure the cell viability ATP treatment significantly reduced cell viability compared with
the NT controls. Pretreatment with AZ 10606120 dihydrochloride prevented the ATP-dependent decrease in cell survival restoring cell viability to levels comparable to NT
samples. (e) P2X7-dependent ATP-induced cell death was further confirmed with EthD-1 staining. Following ATP treatments, the number of death cell stained by EthD-1 was
significantly increased. This was prevented by incubation with the AZ 10606120 dihydrochloride compound. For all assays, statistical analysis was performed using one-way
analysis of variance (ANOVA) followed by Tukey’s multiple comparison test, n¼ 6, **Po0.01, ***Po0.001 and ****Po0.0001)
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effect on endogenous SCs or to an initial regenerative boost
signal from transplanted uASC, which were present in high
number 3 days after transplantation.26
An early death of transplanted SCs was observed in spinal
cord injury models with 78% cell loss within the first week,
without a subsequent decrease in cell number.53 Delaying the
transplantation procedure after injury or injecting SCs in a
non-damaged site improved cell survival up to 60%.54 This
evidence suggests the presence of hostile factors at the injury
site, which can facilitate or induce cell death.53,54 The loss of
cells transplanted into damaged tissue has been associated
with hypoxia at the injury site and to nutrients deprivation
for the cells, which suffer from tissue culture serum star-
vation.55,56 Nonetheless, the impact of other factors capable
of mediating cell death, such as ATP, may not be excluded.
It is a generally accepted knowledge that ATP is released in
high concentrations at injury sites in the central and peripheral
nervous system.49,57 In particular, SCs themselves secrete
ATP during Wallerian degeneration, which rapidly follows
peripheral nerve injury,58 and this ATP affects SC dediffe-
rentiation and proliferation.59 Moreover, damaged cells at the
distal stump of the injury site constitute an additional source of
ATP that could be released during membrane damage and
cell death. The high concentration of ATP detected at the site
of peripheral nerve lesions could be responsible of the low
survival rate of transplanted stem cell.
Peripheral nerve injuries are currently treated by surgery
aimed at rejoining the ends of a damaged nerve or to fill nerve
gaps with an autologous nerve graft.4,60 The outcomes of
this therapeutic approach are not always satisfying and
there is great interest in the development of bioengineered
nerve grafts enriched with cells capable of improving nerve
regeneration.1 Herein, we propose a novel pharmacological
approach to improve the survival rate of transplanted
cells in bioengineered nerve grafts, exploiting functional
P2X7 receptors on dASC. In this scenario, dASC could be
treated with specific P2X7 antagonist before transplantation
to prevent the early cell mortality that occurs at the
injury site.53,54
Materials and Methods
Animals and cell cultures. All the experiments requiring animals were
performed in accordance with the UK Animals (Scientific Procedures) Act, 1986.
Following terminal anaesthesia with CO2 and cervical dislocation, tissues were
collected from the animals and processed as required to obtain the different cell
cultures.
aSC and nSC cultures. SCs were obtained from the sciatic nerves of
neonatal or adult Sprague-Dawley rats using previously established protocols.23,36
Cultures were maintained in low-glucose Dulbecco’s modified Eagle’s medium
(Sigma-Aldrich, Dorset, UK) supplemented with 10% (v/v) of fetal bovine serum
(FBS; Biosera, Uckfield, UK), 1% (v/v) of penicillin-streptomycin solution (P-S;
PAA, Somerset, UK), 10mM forskolin (fsk; Sigma-Aldrich) and 63 ng/ml of glial
growth factor-2 (GGF-2; Acorda Therapeutics Inc., Ardsley, NY, USA). Cells were
incubated in 5% CO2 at 37 1C and maintained at sub-confluent levels onto poly-D-
lysine (Sigma-Aldrich)-coated 75 cm2 flasks, with medium changes every 72 h.
ASCs cultures. ASCs were isolated from subcutaneous, inguinal and visceral
fat pads of male adult Sprague-Dawley rats, as described previously.14 Briefly, the
collected fat pads were joined and mechanically dissociated using sterile scissors
and scalpel blades. The fat pads were then further enzymatically dissociated with
collagenase Type I (Gibco, Life Technologies, Paisley, UK) and finally filtered
through a 100-mm BD Falcon Cell Strainers (BD Bioscience, Oxford, UK) to
remove debris. The resulting cell suspensions were pelleted by 5 min of
centrifugation at 900 r.p.m. and resuspended and plated in alpha-modified Eagle’s
medium (Sigma-Aldrich), containing 1% (v/v) P-S and 10% (v/v) FBS (stem cell
growth media, SCGM). Cultures were maintained on 75 cm2 flasks incubated at
37 1C and 5% CO2. When flasks were confluent, cells were detached with trypsin-
EDTA (Invitrogen, Life Technologies), split and re-plated.
Glial differentiation of stem cells. dASCs were obtained as previously
described.14 Briefly, passage 1–3 ASC cultures were incubated for 24 h in SCGM
containing 1 mM b-mercaptoethanol (Sigma-Aldrich), and this was followed by
3 days of further cell-preconditioning in SCGM supplemented with 35 ng/ml
all-trans-retinoic acid (Sigma-Aldrich). The medium was then replaced with stem
cell differentiation medium containing 5 ng/ml platelet-derived growth factor
(Sera Laboratories International, Haywards Heath, UK), 10 ng/ml basic fibroblast
growth factor (Sera Laboratories International), 14 mM fsk and 126 ng/ml GGF-2
(Acorda Therapeutics Inc.). The cells were incubated for 2 weeks under these
conditions, passaged with trypsin-EDTA when needed, and fresh medium was
added approximately every 72 h. Successful differentiation into a glial phenotype
was confirmed by immunocytochemical assessment of glial markers, as previously
reported.35,36
Reverse transcriptase-PCR. Cells were collected from sub-confluent
flasks of each experimental group (aSC, nSC and ASC before and after glial
differentiation). Total RNA was extracted using RNeasyTM Mini Kit (Qiagen,
Manchester, UK), according to the manufacturer protocol. Extracted RNA was
treated with DNAse (Qiagen) to eliminate genomic contamination and finally eluted
in water. After the measure of the concentrations by ultraviolet spectrophotometry,
1–10 ng of each RNA sample were reverse-transcripted for 30 min at 50 1C and
cDNAs were amplified using One-Step RT-PCR kit (Qiagen) with the following
PCR cycling protocol (35 cycles): 30 s of denaturation at 95 1C for 30 s, annealing
for 1 min (optimal temperatures are indicated Table 1 for each primer pair), primer
extension at 72 1C for 90 s and a final extension step of 10 min at 72 1C. The
primer sequences and product size for all RT-PCRs are described in Table 1. For
P2X1–2 and P2X5–6, 10 ng of RNA was used as starting template. Specific primers
for the housekeeping gene, b-actin were used to confirm reverse transcription and
ensure equal loading (see Table 1). A reaction omitting the template was carried
out as a negative control.
Western blot analysis. Whole-cell lysates were obtained by scraping cells
from confluent flasks using a lysis buffer containing 20 mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES, pH 7.4) buffer, 100 mM NaCl, 1% (v/v)
Nonidet P-40, 5 mM EDTA and a cocktail of protease and phosphatase inhibitors
(Thermo Scientific, Loughborough, UK). Lysates were incubated for 30 min on ice
and, after freeze-thaw, protein concentrations were determined using the Bio-Rad
detergent-compatible protein assay (Bio-Rad Laboratories, Hemel Hempstead,
UK). Before loading, proteins were denaturated for 5 min at 95 1C in reducing
NuPAGE LDS sample buffer, and 30 mg of proteins were separated at 160 V for
1 h on Bis-Tris gels NuPage Novex gels (Life Technologies, UK). Following
electrophoretic separation, the proteins were transferred to nitrocellulose
membranes (GE Healthcare, Little Chalfont, UK) for 1 h at 350 mA. In order to
confirm successful protein transfer, membranes were stained with Pounceau red
(Sigma, UK), before being blocked for 30 min in a Tris-buffered saline (TBS)-
Tween solution (20 mM Tris pH 8, 250 mM NaCl, 0.1% (v/v) Tween) containing 5%
(w/v) of non-fat dry milk. The membranes were thus incubated at 4 1C in the
following primary antibodies diluted in blocking buffer: rabbit polyclonal anti-P2X4
(1 : 500; Alomone Labs, Jerusalem, Israel) and rabbit polyclonal anti-P2X7
(1 : 500; Alomone Labs). After overnight incubation, membranes were washed with
TBS-Tween and thus incubated for 1 h with an anti-rabbit horseradish peroxidase-
conjugated (HRP) secondary antibody (1 : 2000; Cell Signaling, Hitchin, UK) for
chemiluminescence detection. Finally, blots were stripped for 30 min at room
temperature with a stripping buffer (Thermo Scientific) to remove the antibodies
bound to the nitrocellulose. After further blocking in TBS milk, membranes were
re-probed, using a rabbit primary antiserum directed against b-tubulin (1 : 2000,
Abcam, Cambridge, UK), followed by antigen detection with an anti-rabbit HRP-
conjugated secondary antibody (1 : 2000; Cell Signaling). Membranes were
exposed to SuperSignal West Pico Chemiluminescent Substrate (Thermo
Scientific) for signal detection, and images were acquired with a Kodak Image
Station 4000 mm pro digital imaging system (Kodak, Rochester, NY, USA).
P2X7 receptors mediate SC-like stem cell death
A Faroni et al
9
Cell Death and Disease
Immunocytochemistry. Cells from each experimental group were plated on
chamber slides (Nunc-Fisher Scientific, UK) or glass coverslips at a density of
5 103 cells per cm2 for all immunocytochemical studies. Twenty-four hours after
seeding, cells were fixed for 15 min in 4% (w/v) paraformaldehyde (Sigma-Aldrich)
and washed in phosphate-buffered solution (PBS). After 30 min of permeabi-
lisation with 0.2% (v/v) Triton X-100 at room temperature, slides and coverslips
were blocked for 1 h with normal goat or donkey serum solution (both 1 : 100;
Sigma). The following primary antibodies were applied overnight at 4 1C for P2X4
(rabbit polyclonal 1 : 1000; Alomone), P2X7 (rabbit polyclonal 1 : 1000; Alomone)
and GFAP (mouse monoclonal 1 : 500; Thermo Scientific). After 24 h, slides were
rinsed in PBS before incubation in Alexa Fluor 488 goat anti-rabbit IgG or Alexa
Fluor 568 donkey anti-mouse IgG secondary antibodies (both from Life
Technologies), depending on the host species of the primary antibodies. After
final washing with PBS, slides were mounted using Vectashield mounting medium
for fluorescence containing 40,6- diamidino-2-phenylindole for nuclear staining
(Vector Laboratories, Peterborough, UK). Finally, images were acquired using a
fluorescence microscope (Olympus BX60, Southend-on-Sea, UK) and processed
with ImageJ 64 imaging software (National Institutes of Health NIH, Bethesda, MD,
USA).
Calcium imaging techniques. For intracellular Ca2þ measurements
cells were seeded at confluence on glass coverslips (for confocal imaging
analysis) or on 96-well essay plates (Corning, CellBIND surface, Tewksbury,
MA, USA, for multiplate reader measurements). After overnight incubation,
cells were loaded for 40 min at 37 1C with 3 mM of Fluo-4-AM or 10 mM Fura-
2-AM in Krebs-Ringer-modified buffer (KRB): 136 mM NaCl, 20 mM HEPES,
5.5 mM glucose, 1.2 mM KH2PO4, 1.2 mM MgSO4, 5 mM NaHCO3, 1.8 mM
KCl, 2 mM CaCl2 pH 7.4 (all from Sigma-Aldrich) supplemented with 0.01%
pluronic acid (Molecular Probes, Life Technologies). For confocal imaging
using Fluo-4, after de-esterification in KRB (20 min at 37 1C), the coverslips
were placed in a perfusing chamber, mounted on the stage of an inverted
confocal microscope (Nikon Eclipse TE300; Nikon UK ltd, Surrey, UK). Cells
were superfused with KRB at 8 ml/min, maintained at 37 1C and excited at
488 nm by excitation laser (emitted light filtered at 515±30 nm). Images
were acquired using  20 dry objective (NA 0.5). Drugs were applied by
superfusion. Similarly, for Flexstation multiplate reader measurements
(Flexstation 3, Molecular Devices, Sunnyvale, CA, USA), the cells were
loaded with Fura-2-AM and de-esterified for 20 min at 37 1C. Cultures were
excited at 335 and 363 nm, and emission was measured at 510 nm. ATP
treatments were performed after 20 s and fluorescence emission was
monitored for 4 min. Technically, it was not possible to test ATP
concentrations 41 mM because, at higher concentrations, cells detached
from the coverslips and from the tissue culture plates making fluorescence
detection impossible with the Flexstation system. For the experiments
investigating the contribution of P2Y receptors to intracellular Ca2þ
increase, Ca2þ was omitted from the KRB solution. In the Flexstation
measurements, cells were preincubated for 10 min with a potent P2X7-
specific inhibitor (AZ 10606120 dihydrochloride, 300 nM, Tocris Bioscience,
Bristol, UK) before treatment with ATP 1 mM (Sigma-Aldrich). Data were
expressed as a ratio between the fluorescence recorded after stimulation
(335/363 nm, n¼ 4). For the quantification of the AUC in Flestation
experiments, GraphPad Prism (GraphPad Software Inc., San Diego, CA,
USA) was used setting the first three data point of each curve as baseline.
Data were expressed as AUC arbitrary units±S.E.M.
Electrophysiology. dASC and uASCs (3 103) were seeded separately
onto 12-mm-diameter glass coverslips. Recording pipettes were pulled from
borosilicate glass (Harvard Apparatus, Kent, UK) and had resistances of 2–5 MO
when filled with the intracellular pipette solution containing (in mM) 147 NaCl, 10
HEPES and 10 EGTA. This solution contained (in mM) 147 NaCl, 10 HEPES, 13
glucose, 2 KCl, 2 CaCl2 and 1 MgCl2. All solutions were maintained at 300–
320 mOsm/l and pH 7.3 (adjusted with NaOH). Whole-cell patch clamp recordings
were made at room temperature using a HEKA EPC9 patch clamp amplifier and
Pulse acquisition software (HEKA, Lambrecht, Germany). Recordings were made
at a holding potential of  60 mV. The data were low-pass filtered at 3 kHz and
sampled at 1 kHz. Solutions were directly applied to cells using an RSC-160 rapid
perfusion system (Biologic Science Instruments, Claix, France-Ise`re, France), with
tubes positioned B100mm away from the cell. Current amplitudes were
expressed as current densities (pA/pF).
Cell death and survival assays. To investigate the effect of P2X7
receptors stimulation on cell death and survival, dASC cultures were treated with
ATP in the presence of the specific P2X7 antagonist AZ 10606120 dihydrochloride
(300 nM).
Cytotoxicity was assessed via a Cytotoxicity Detection Kit (Roche Applied
Science, Burgess Hill, UK), a colorimetric assay based on the measurement of LDH
released from the cytosol of damaged cells in the cytoplasm. Briefly, cells were
seeded on 96-well essay plates (Corning, CellBIND surface) at a density of 2 105
cells per well. After overnight incubation, cells were washed with KRB and
preincubated for 10 min with AZ 10606120 dihydrochloride (300 nM) in KRB, and
controls were treated with drug vehicle. After 10 min incubation at 37 1C and 5%
CO2, cells were treated for 1 h with 5 mM ATP to induce cell death. In the
experiments for the determination of the optimal ATP concentration, cells were
incubated in KRB only before ATP (1–10 mM) treatments. NT controls were used to
assess spontaneous LDH release and NT cells lysed with Triton X-100 were used to
determine the total amount of LDH in the cytoplasm. After 1 h incubation,
supernatant were collected and spun at 1500 r.p.m. for 5 min at 4 1C to remove cell
debris. The cytotoxicity assay was performed according to manufacturer’s protocol
and LDH levels were measured by absorbance reading at 492 nm using a Asys
UVM-340 microplate reader/spectrophotometer (Biochrom Ltd., Cambridge, UK).
Data were expressed as percentage versus Triton X-100 cell lysates±S.E.M.
(n¼ 6).
To further prove ATP-induced cell death, a different cell viability assay based on
the membrane-impermeant viability indicator EthD-1 (Molecular Probes) was
performed. This high-affinity nucleic-acid stain binds DNA of dead cells and emits
red fluorescence. Cells were seeded and treated as in LDH assay, and were
incubated overnight at 37 1C and 5% CO2. At the end of the pharmacological
treatments, cells were incubated for 20 min at 37 1C in 4 mM EthD-1 in KRB. At the
end of the incubation, cells were examined under a fluorescent inverted microscope
(Olympus IX51). For each well, an image covering anB50% of the surface area
was acquired and the stained cells were counted using the counting tool of Image
Pro Plus image analysis software (Media Cybernetics, Rockville, MD, USA). Data
were expressed as dead cells per field±S.E.M. (n¼ 6).
Cell survival was assessed via the CellTiter 96 AQueous One Solution Cell
Proliferation Assay (Promega, Southampton, UK), a colorimetric method for
determining the number of viable cells based on a novel tetrazolium compound,
inner salt (MTS). MTS is bioreduced by viable cells into a coloured formazan
compound. Cells were seeded and treated as for the cytotoxicity assay;
nevertheless, following ATP treatment cells were incubated with the MTS solution
according to manufacturer’s protocol for 3 h, and absorbance at 490 nm was
measured using a Asys UVM-340 microplate reader/spectrophotometer (Biochrom
Ltd.). Data were expressed as percentage versus the NT controls±S.E.M. (n¼ 6).
Statistical analyses. Statistical significance for electrophysiology, cell death
and survival assays was estimated by one-way analysis of variance with Tukey’s
multiple comparison tests, using GraphPad Prism 6 (GraphPad Software Inc.). For
Flexstation studies, unpaired t-test was performed. Levels of significance were
expressed as P-values (*Po0.05, **Po0.01, ***Po0.001 and ****Po0.0001).
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